NDC 70095-060 – Pomalidomide
Pomalidomide 4 mg/1 · Capsule · Oral
Product NDC70095-060
Product details
- Brand name
- Pomalidomide
- Generic name
- Pomalidomide
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA210232
- Marketed since
- August 31, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Thalidomide Analog
Active ingredients
- Pomalidomide 4 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 70095-060-01 | 21 CAPSULE in 1 BOTTLE (70095-060-01) | Aug 31, 2026 |
| 70095-060-02 | 100 CAPSULE in 1 BOTTLE (70095-060-02) | Aug 31, 2026 |
Other Pomalidomide products
- 60505-4498 Pomalidomide 2 mg/1 · Capsule · Apotex Corp.
- 60505-4499 Pomalidomide 3 mg/1 · Capsule · Apotex Corp.
- 60505-4500 Pomalidomide 4 mg/1 · Capsule · Apotex Corp.
- 60505-4497 Pomalidomide 1 mg/1 · Capsule · Apotex Corp.
- 59651-197 Pomalidomide 4 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-195 Pomalidomide 2 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-196 Pomalidomide 3 mg/1 · Capsule · Aurobindo Pharma Limited
- 59651-194 Pomalidomide 1 mg/1 · Capsule · Aurobindo Pharma Limited
- 51991-342 Pomalidomide 1 mg/1 · Capsule · Breckenridge Pharmaceutical, Inc.
- 51991-344 Pomalidomide 3 mg/1 · Capsule · Breckenridge Pharmaceutical, Inc.
- 51991-346 Pomalidomide 4 mg/1 · Capsule · Breckenridge Pharmaceutical, Inc.
- 51991-343 Pomalidomide 2 mg/1 · Capsule · Breckenridge Pharmaceutical, Inc.